It is known that in OSAS the plasma lipid peroxidation has an opposite behavior in comparison with nitric oxide metabolites. In the re-examination of our survey of OSAS subjects we calculated the ratio between thiobarbituric acid reactive substances (TBARS) and nitric oxide metabolites (NOx) in relation to OSAS severity. The study has regarded 48 OSAS subjects subdivided in two subgroups according to the apnea/hypopnea index – AHI- (Low = 21 subjects with AHI <30 and High = 27 subjects with AHI >30). From the obtained data it is evident that the TBARS/NOx ratio is significantly higher in the H subgroup compared to L subgroup as well as this ratio is reduced in L subgroup in comparison with the whole group of OSAS subjects. In the entire group of OSAS subjects the TBARS/NOx ratio results positively correlated with AHI and ODI and inversely correlated with mSO2.
BarathA., NemethI., KargE., EndreffyC., BereczkyC., GellenB., HaszonI. and TuriS., Roles of paroxonase and oxidative stress in adolescents with uraemic, essential or obesity-induced hypertension, Kidney Blood Pressure Research29 (2006), 144–151.
2.
BarathA., TuriS., NemethI., BereczkyC., GellenB., HaszonI. and MonostoriP., Different pathomechanisms of essential and obesity-associated hypertension in adolescents, Pediatric Nephrology21 (2006), 1419–1425.
3.
BarcelòA., MirallesC., BarbéF., VilaM., PonsS. and AgustíA.G., Abnormal lipid peroxidation in patients with sleep apnoea, European Respiratory Journal16 (2000), 644–647.
4.
CaimiG., Lo PrestiR., MontanaM., NotoD., CaninoB., AvernaM.R. and HoppsE., Lipid peroxidation, nitric oxide metabolites, and their ratio in a group of subjects with metabolic syndrome, Oxidative Medicine & Cellular Longevity2014 (2014), 824756.
5.
CaimiG., MulèG., HoppsE., CarolloC. and Lo PrestiR., Nitric oxide metabolites and oxidative stress in mild essential hypertension, Clinical Hemorheology and Microcirculation46(4) (2010), 321–325.
6.
CaninoB., HoppsE., CalandrinoV., MontanaM., Lo PrestiR. and CaimiG., Nitric oxide metabolites and erythrocyte deformability in a group of subjects with obstructive sleep apnea syndrome, Clinical Hemorheology and Microcirculation59(1) (2015), 45–52.
7.
CelecP., HodosyJ., BehuliakM., PálffyR., GardlíkR., HalčákL. and MucskaI., Oxidative and carbonyl stress in patients with obstructive sleep apnea treated with continuous positive airway pressure, Sleep & Breathing16(2) (2012), 393–398.
8.
ChungA.W., HsiangY.N., MatzkeL.A., McManusB.M., van BreemenC. and OkonE.B., Reduced expression of vascular endothelial growth factor paralleled with the increased angiostatin expression resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in human type 2 diabetic arterial vasculature, Circulation Research99 (2006), 140–148.
9.
CoftaS., WysockaE., PiorunekT., RzymkowskaM., Batura-GabryelH. and TorlinskiL., Oxidative stress markers in the blood of persons with different stages of obstructive sleep apnea syndrome, Journal of Physiology and Pharmacology59 (2008), 183–190.
10.
De Torres-AlbaF., GemmaD., Armada-RomeroE., Rey-BlasJ.R., López-de-SáE. and López-SendonJ.L., Obstructive sleep apnea and coronary artery disease: From pathophysiology to clinical implications, Pulmonary Medicine2013 (2013), 768064.
11.
EpsteinL.J., KristoD., StrolloP.J.Jr, FriedmanN., MalhotraA., PatilS.P., RamarK., RogersR., SchwabR.J., WeaverE.M. and WeinsteinM.D., Adult obstructive sleep apnea task force of the american academy of sleep medicine, Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults, Journal of Clinical Sleep Medicine5 (2009), 263–276.
12.
FlorasJ.S., Sleep apnea and cardiovascular risk, Journal of Cardiology63 (2014), 3–8.
13.
HoppsE., CaninoB., CalandrinoV., MontanaM., Lo PrestiR. and CaimiG., Lipid peroxidation and protein oxidation are related to the severity of OSAS, European Review for Medical and Pharmacological Sciences18(24) (2014), 3773–3778.
14.
HoppsE., CaninoB., MontanaM., CalandrinoV., UrsoC., Lo PrestiR. and CaimiG., Gelatinases and their tissue inhibitors in a group of subjects with obstructive sleep apnea syndrome, Clinical Hemorheology and Microcirculation (2015), [Epub ahead of print].
15.
JelicS., PadelettiM., KawutS.M., HigginsC., CanfieldS.M., OnatD., ColomboP.C., BasnerR.C., FactorP. and LeJemtelT.H., Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea, Circulation117 (2008), 2270–2278.
16.
KatsoulisK., KontakiotisT., SpanogiannisD., VlachogiannisE., KougioulisM., GerouS. and DaskalopoulouE., Total antioxidant status in patients with obstructive sleep apnea without comorbidities: The role of the severity of the disease, Sleep & Breathing15(4) (2011), 861–866.
17.
KendzerskaT., GershonA.S., HawkerG., LeungR.S. and TomlinsonG., Obstructive sleep apnea and risk of cardiovascular events and all-cause mortality: A decade long-historical cohort study, Plos One11 (2014), e10001599.
18.
KimoffR.J., HamidQ., DivangahiM., HussainS., BaoW., NaorN., PayneR.J., AriyarajahA., MulrainK. and PetrofB.J., Increased upper airway cytokines and oxidative stress in severe obstructive sleep apnoea, European Respiratory Journal38 (2010), 89–97.
19.
KonecnyT., KaraT. and SomersV.K., Obstructive sleep apnea and hypertension: An update, Hypertension63 (2014), 203–209.
20.
KumarC.A. and DasU.N., Lipid peroxides, anti-oxidants and nitric oxide in patients with pre-eclampsia and essential hypertension, Medical Science Monitoring6 (2000), 901–907.
21.
LavieL. and LavieP., Molecular mechanisms of cardiovascular disease in OSAHS: The oxidative stress link, European Respiratory Journal33 (2009), 1467–1484.
22.
Lo PrestiR., CaninoB., MontanaM. and CaimiG., Lipid peroxidation and nitric oxide metabolites in sedentary subjects and sportsmen before and after a cardiopulmonary test, Clinical Hemorheology and Microcirculation54(1) (2013), 39–49.
23.
MancusoM., BonanniE., LoGerfoA., OrsucciD., MaestriM., ChicoL., DiCoscioE., FabbriniM., SicilianoG. and MurriL., Oxidative stress biomarkers in patients with untreated obstructive sleep apnea syndrome, Sleep Medicine13 (2012), 632–636.
24.
MarinJ.M., CarrizoS.J., VicenteE. and AgustiA.G., Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: An observational study, Lancet365(9464) (2005), 1046–1053.
25.
MehraR., BenjaminE.J., ShaharE., GottliebD.J., NawabitR., KirchnerH.L., SahadevanJ. and RedlineS., Sleep Heart Health Study, Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study, American Journal of Respiratory and Critical Care Medicine173 (2006), 910–916.
26.
MurriM., Alcázar-RamírezJ., Garrido-SánchezL., LindeF., AlcaideJ., CardonaF. and TinahonesF.J., Oxidative stress and metabolic changes after continuous positive airway pressure treatment according to previous metabolic disorders in sleep apnea-hypopnea syndrome patients, Translational Research154 (2009), 111–121.
27.
MurriM., Garcia-DelgadoR., Alcázar-RamírezJ., LindeF., Fernández-RamosA., CardonaF. and TinahonesF.J., Assessment of cellular and plasma oxidative stress in SAHS patients before and after continuous positive airway pressure treatment, Clinical Laboratory56 (2010), 397–406.
28.
NodaA., NakataS., KoikeY., MiyataS., KitaichiK., NishizawaT., NagataK., YAsumaF., MuroharaT. and YokotaM., Continuous positive airway pressure improves daytime baroreflex sensitivity and nitric oxide production in patients with moderate to severe obstructive sleep apnea syndrome, Hypertension Research30 (2007), 669–676.
29.
PintoP., BàrbaraC., MontserratJ.M., PatarraoR.S., GuarinoM.P., CarmoM.M., MacedoM.P., MartinhoC., DiasR. and GomesM.J.M., Effects of cPAP on nitrate and norepinephrine levels in severe and mild-moderate sleep apnea, BMC Pulmonary Medicine13 (2013), 13.
30.
SinghT.D., PatialK., VijayanV.K. and RaviK., Oxidative stress and obstructive sleep apnoea syndrome, Indian Journal of Chest Diseases and Allied Sciences51 (2009), 217–224.
31.
TuriS., FriedmanA., BereczkyC., PappF., KovacsJ., KargE. and NemethI., Oxidative stress in juvenile essential hypertension, Journal of Hypertension21 (2003), 145–152.
32.
WangB., YanD., SonX. and Ye LiuS.F., Chronic intermittent hypoxia down-regulates endothelial nitric oxide synthase expression by an NF-kB-dependent mechanism, Sleep Medicine14 (2013), 165–171.
33.
ZhaoH.Y., ChenB.Y., CaoJ., FengJ. and GuoM.N., Effects of obstructive sleep apnea style intermittent hypoxia on endothelin-1, nitric oxide, and nitric oxide synthase in endothelium: Experiment with human umbilical vein endothelial cells, Zhonghua Yi Xue Za Zhi87 (2007), 2189–2192.
